(Q44367885)

English

Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Niels Bagge

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 December 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Acta Pathologica et Microbiologica Scandinavica

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

110

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

881-891

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Bacterial biofilms: a common cause of persistent infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Antibodies against chromosomal beta-lactamase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis Patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

New antimicrobials in the management of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Selection and application of antibodies modifying the function of beta-lactamase.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

21 January 2018

Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamases.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergy between acylureidopenicillins and immunoglobulin G in experimental animals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Terminal truncations in amp C beta-lactamase from a clinical isolate of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification and properties of cephalosporinase from Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-induced conformational changes in proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on penicillinase; the effect of antipenicillinase on penicillin-resistant organisms

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The reversible deactivation of beta-lactamase from Staphylococcus aureus by quinacillin and cephaloridine and its modification by antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracellular polysaccharides do not inhibit the reaction between Streptococcus mutans and its specific immunoglobulin G (IgG) or penetration of the IgG through S. mutans biofilm

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101207.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0463.2002.1101207.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12645667%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44367885&oldid=2049134517"